Literature DB >> 33602941

Histamine H1 receptor deletion in cholinergic neurons induces sensorimotor gating ability deficit and social impairments in mice.

Li Cheng1,2, Cenglin Xu1,2, Lu Wang1, Dadao An1, Lei Jiang1, Yanrong Zheng1, Yixin Xu1, Yi Wang1,2, Yujing Wang1, Kuo Zhang3, Xiaodong Wang1, Xiangnan Zhang1, Aimin Bao1, Yudong Zhou1, Jingyu Yang3, Shumin Duan1, Dick F Swaab4, Weiwei Hu5, Zhong Chen6,7.   

Abstract

Negative symptoms in schizophrenia strongly contribute to poor functional outcomes, however its pathogenesis is still unclear. Here, we found that histamine H1 receptor (H1R) expression in basal forebrain (BF) cholinergic neurons was decreased in patients with schizophrenia having negative symptoms. Deletion of H1R gene in cholinergic neurons in mice resulted in functional deficiency of cholinergic projections from the BF to the prefrontal cortex and in the formation of sensorimotor gating deficit, social impairment and anhedonia-like behavior. These behavioral deficits can be rescued by re-expressing H1R or by chemogenetic activation of cholinergic neurons in the BF. Direct chemogenetic inhibition of BF cholinergic neurons produced such behavioral deficits and also increased the susceptibility to hyperlocomotion. Our results suggest that the H1R deficiency in BF cholinergic neurons is critical for sensorimotor gating deficit, social impairments and anhedonia-like behavior. This finding may help to understand the genetic and biochemical bases of negative symptoms in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33602941      PMCID: PMC7893046          DOI: 10.1038/s41467-021-21476-x

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  62 in total

1.  Impaired recognition memory in rats after damage to the hippocampus.

Authors:  R E Clark; S M Zola; L R Squire
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

2.  Lifelong course of positive and negative symptoms in chronically institutionalized patients with schizophrenia.

Authors:  Branislav Mancevski; John Keilp; Matthew Kurzon; Robert M Berman; Vladimir Ortakov; Jill Harkavy-Friedman; Gorazd Rosoklija; Andrew J Dwork
Journal:  Psychopathology       Date:  2007-01-11       Impact factor: 1.944

3.  Cholinesterase inhibitors ameliorate behavioral deficits induced by MK-801 in mice.

Authors:  John G Csernansky; Maureen Martin; Renu Shah; Amy Bertchume; Jenny Colvin; Hongxin Dong
Journal:  Neuropsychopharmacology       Date:  2005-12       Impact factor: 7.853

4.  Involvement of histamine receptors in the atypical antipsychotic profile of clozapine: a reassessment in vitro and in vivo.

Authors:  Marie Humbert-Claude; Elisabeth Davenas; Florence Gbahou; Ludwig Vincent; Jean-Michel Arrang
Journal:  Psychopharmacology (Berl)       Date:  2011-09-13       Impact factor: 4.530

5.  Developmental vitamin D deficiency alters MK 801-induced hyperlocomotion in the adult rat: An animal model of schizophrenia.

Authors:  James P Kesby; Thomas H J Burne; John J McGrath; Darryl W Eyles
Journal:  Biol Psychiatry       Date:  2006-05-12       Impact factor: 13.382

Review 6.  Histamine and histamine receptors in Tourette syndrome and other neuropsychiatric conditions.

Authors:  Maximiliano Rapanelli; Christopher Pittenger
Journal:  Neuropharmacology       Date:  2015-08-14       Impact factor: 5.250

7.  Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: their relationships to levels of other aminergic transmitters and ratings of symptoms.

Authors:  G D Prell; J P Green; C A Kaufmann; J K Khandelwal; A M Morrishow; D G Kirch; M Linnoila; R J Wyatt
Journal:  Schizophr Res       Date:  1995-01       Impact factor: 4.939

Review 8.  Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior.

Authors:  Marina R Picciotto; Michael J Higley; Yann S Mineur
Journal:  Neuron       Date:  2012-10-04       Impact factor: 17.173

9.  Decreased glutamic acid decarboxylase(67) mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders.

Authors:  Mia Thompson; Cynthia Shannon Weickert; Eugene Wyatt; Maree J Webster
Journal:  J Psychiatr Res       Date:  2009-03-24       Impact factor: 4.791

10.  Clinical evaluation of negative symptoms in schizophrenia.

Authors:  Hans-Jürgen Möller
Journal:  Eur Psychiatry       Date:  2007-05-23       Impact factor: 5.361

View more
  7 in total

Review 1.  Targeting Histamine and Histamine Receptors for the Precise Regulation of Feeding.

Authors:  Yanrong Zheng; Zhong Chen
Journal:  Curr Top Behav Neurosci       Date:  2022

Review 2.  Revisiting Preclinical Observations of Several Histamine H3 Receptor Antagonists/Inverse Agonists in Cognitive Impairment, Anxiety, Depression, and Sleep-Wake Cycle Disorder.

Authors:  Mera Alhusaini; Nermin Eissa; Ali K Saad; Rami Beiram; Bassem Sadek
Journal:  Front Pharmacol       Date:  2022-06-01       Impact factor: 5.988

3.  Histamine H1 Receptor in Basal Forebrain Cholinergic Circuit: A Novel Target for the Negative Symptoms of Schizophrenia?

Authors:  Shuangshuang Wu; Chenshu Gao; Feng Han; Heming Cheng
Journal:  Neurosci Bull       Date:  2021-12-27       Impact factor: 5.203

Review 4.  Basal Forebrain Cholinergic Neurons: Linking Down Syndrome and Alzheimer's Disease.

Authors:  Jose L Martinez; Matthew D Zammit; Nicole R West; Bradley T Christian; Anita Bhattacharyya
Journal:  Front Aging Neurosci       Date:  2021-07-12       Impact factor: 5.702

5.  Disrupted presynaptic nectin1-based neuronal adhesion in the entorhinal-hippocampal circuit contributes to early-life stress-induced memory deficits.

Authors:  Chen Wu; Qian Gong; Xue Xu; Ping Fang; Chi Wang; Jing-Ying Yu; Xing-Xing Wang; San-Hua Fang; Wen-Juan Chen; Hui-Fang Lou; Yu-Hui Liu; Liang Wang; Yi-Jun Liu; Wei Chen; Xiao-Dong Wang
Journal:  Transl Psychiatry       Date:  2022-04-04       Impact factor: 7.989

Review 6.  Histamine, Neuroinflammation and Neurodevelopment: A Review.

Authors:  Elliott Carthy; Tommas Ellender
Journal:  Front Neurosci       Date:  2021-07-14       Impact factor: 4.677

Review 7.  The Histaminergic System in Neuropsychiatric Disorders.

Authors:  Li Cheng; Jiaying Liu; Zhong Chen
Journal:  Biomolecules       Date:  2021-09-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.